- Previous Close
31.30 - Open
31.30 - Bid 30.82 x --
- Ask 30.90 x --
- Day's Range
30.44 - 31.30 - 52 Week Range
9.07 - 31.60 - Volume
671,332 - Avg. Volume
1,669,509 - Market Cap (intraday)
2.175B - Beta (5Y Monthly) 0.49
- PE Ratio (TTM)
-- - EPS (TTM)
-0.04 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Rhea Venture Capital Investment Trust Inc is a venture capital investment trust specializing in seed/startup, early, mid venture, middle market, buyouts, PIPEs investments in small and medium enterprises. The fund seeks to invest in healthcare including all areas except hospital services (medical equipment, pharma, distribution, logistics, consumables, IT, laboratories, insurance, and payment systems); telecom, technology including IT, software, hardware, media, internet; infrastructure including energy, waste management, logistics, clean technology; and business services including finance, hospitality, and education. It prefers to invest in Turkey. The fund typically invests between $1 million and $10 million in companies with sales between $5 million and $20 million and EBITDA between $0.75 million and $3 million. It prefers to take a majority stake. However, the fund can also selectively invest with a minority stake. It seeks to hold financial and board level control in its portfolio companies. The fund seeks to exit its investments in five years either through a block sale or an IPO.
www.rheagirisim.com/en3
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: ICUGS.IS
View MorePerformance Overview: ICUGS.IS
Trailing total returns as of 1/10/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ICUGS.IS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ICUGS.IS
View MoreValuation Measures
Market Cap
2.18B
Enterprise Value
1.99B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
28.22
Price/Book (mrq)
5.57
Enterprise Value/Revenue
25.76
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-2.03%
Return on Equity (ttm)
-27.27%
Revenue (ttm)
13.21M
Net Income Avi to Common (ttm)
-53.75M
Diluted EPS (ttm)
-0.04
Balance Sheet and Cash Flow
Total Cash (mrq)
167.58M
Total Debt/Equity (mrq)
10.07%
Levered Free Cash Flow (ttm)
-5.01M